
NASDAQ · BLRX
BioLineRx Ltd.
Healthcare · Biotechnology
$2.02
Up+$0.02 (+1.00%)
Updated Oct 30, 2026, 8:31 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 14.09M
- P/E ratio
- -1.61
- Dividend yield
- 0.00%
- 52-week range
- $1.94 – $3.95
- Volume
- 4.15K
- Avg. volume
- 34.05K
Price performance · BLRX
BLRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
BLRX closed at $2.02 after 21 trading sessions, down 14.04% for the selected period.
- Last close
- $2.02
- Period change
- -14.04%
- Period low
- $1.98
- Period high
- $2.37
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $2.01 | $2.02 | $1.94 | $2.02 | 4.15K |
| Oct 28, 2026 | $1.94 | $2.04 | $1.94 | $2.00 | 4.04K |
| Oct 27, 2026 | $1.97 | $2.03 | $1.96 | $2.03 | 4.99K |
| Oct 26, 2026 | $2.15 | $2.15 | $1.98 | $2.01 | 8.04K |
| Oct 23, 2026 | $2.04 | $2.11 | $2.04 | $2.04 | 1.7K |
| Oct 22, 2026 | $2.07 | $2.166 | $1.99 | $2.0635 | 5.2K |
| Oct 21, 2026 | $2.19 | $2.19 | $1.96 | $2.11 | 1.86K |
| Oct 20, 2026 | $2.07 | $2.2145 | $2.07 | $2.2145 | 3.06K |
| Oct 19, 2026 | $2.07 | $2.1599 | $1.96 | $1.98 | 34.66K |
| Oct 16, 2026 | $2.30 | $2.30 | $1.985 | $2.01 | 12.58K |
| Oct 15, 2026 | $2.03 | $2.165 | $1.945 | $2.05 | 28.75K |
| Oct 14, 2026 | $2.18 | $2.18 | $2.0101 | $2.075 | 23.53K |
| Oct 13, 2026 | $2.27 | $2.27 | $2.11 | $2.17 | 11.75K |
| Oct 12, 2026 | $2.22 | $2.3443 | $2.14 | $2.17 | 28.17K |
| Oct 9, 2026 | $2.20 | $2.2703 | $2.20 | $2.216 | 9.69K |
| Oct 8, 2026 | $2.31 | $2.31 | $2.17 | $2.21 | 18.37K |
| Oct 7, 2026 | $2.28 | $2.3698 | $2.16 | $2.205 | 24.04K |
| Oct 6, 2026 | $2.31 | $2.40 | $2.26 | $2.2922 | 22.87K |
| Oct 5, 2026 | $2.36 | $2.36 | $2.29 | $2.32 | 20.26K |
| Oct 2, 2026 | $2.31 | $2.37 | $2.31 | $2.37 | 3.13K |
| Oct 1, 2026 | $2.32 | $2.3886 | $2.32 | $2.35 | 7.58K |
Latest BLRX news
The latest Smart Investors Daily articles mentioning BLRX.
Stock researchResearch & News · News
Company
Market Activity
Research & News

